Binding modes of noncompetitive AMPA antagonists: A computational approach

Farmaco

Volumn 58, Issue 2, 2003, Pages 107-113

  De Luca, Laura ^a   Macchiarulo, Antonio ^b   Costantino, Gabriele ^b   Barreca, Maria Letizia ^a   Gitto, Rosaria ^a   Chimirri, Alba ^a   Pellicciari, Roberto ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

AMPA; Homology modeling; LIVBP; Uncompetitive antagonists

Indexed keywords

AMPA RECEPTOR ANTAGONIST; BINDING PROTEIN; ISOLEUCINE; LEUCINE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; VALINE;

AMINO TERMINAL SEQUENCE; ARTICLE; DRUG BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; BINDING SITES; COMPUTATIONAL BIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; MOLECULAR SEQUENCE DATA; RECEPTORS, AMPA;

EID: 0037318781     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(02)00027-7     Document Type: Article

References (21)

1. Madden D.R. The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci. 3:2002;91-101.
2. Pellicciari R., Costantino G. Metabotropic G-protein-coupled glutamate receptors as therapeutic targets. Curr. Opin. Chem. Biol. 3:1999;433-440.
3. P.J. O'Hara, P.O. Sheppard, H. Thogersen, D. Venezia, B.A. Haldeman, V. McGrane, K.M. Houamed, C. Thomsen, T.L. Gilbert, E.R. Mulvihill, The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins, Neuron 11 (1993), 41-52, 11-52.
4. Fukami-Kobayashi K., Tateno Y., Nishikawa K. Domain dislocation: a change of core structure in periplasmic binding proteins in their evolutionary history. J. Mol. Biol. 286:1999;279-290.
5. Galvez T., Parmentier M.L., Joly C., Malitschek B., Kaupmann K., Kuhn R., Bittiger H., Froestl W., Bettler B., Pin J.P. Mutagenesis and modeling of the GABAB receptor extracellular domain support a venus flytrap mechanism for ligand binding. J. Biol. Chem. 274:1999;13362-13369.
6. Paas Y. The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci. 21:1998;117-125.
7. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature. 407:2000;971-977.
8. Armstrong N., Gouaux E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron. 28:2000;165-181.
9. Tygesen C.K., Jorgensen M., Andersen P.H. The importance of two specific domains in ligand binding to the AMPA/kainate glutamate receptors GluR2 and GluR6. FEBS Lett. 363:1995;184-188.
10. Paoletti P., Perin-Dureau F., Fayyazuddin A., Le Goff A., Callebaut I., Neyton J. Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit. Neuron. 28:2000;911-922.
11. Perin-Dureau F., Ascher P., Paoletti P. Abstr. Soc. Neurosci. 703.4:2001;359.
12. Kuusinen A., Abele R., Madden D.R., Keinanen K. Oligomerization and ligand-binding properties of the ectodomain of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunit GluRD. J. Biol. Chem. 274:1999;28937-28943.
13. Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., Morikawa K. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature. 407:2000;971-977.
14. Luthy R., Bowie J.U., Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature. 356:1992;83-85. http://www.doe-mbi.ucla.edu/Services/Verify_3D.
15. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Olson A.J. Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function. J. Comput. Chem. 19:1998;1639-1662.
16. (a) S.D. Donevan, M.A. Rogawski, GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses, Neuron 10 (1993) 51-59.
17. (b) F. Andrási, Talampanel, drugs of the future, 26 (2001) 754-756.
18. (c) A. Chimirri, G. De Sarro, A. De Sarro, R. Gitto, S. Grasso, S. Quartarone, M. Zappalà, P. Giusti, V. Libri, A. Constanti, A.G. Chapman, 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists, J. Med. Chem. 40 (1997) 1258-1269.
19. (d) J.C. Pelletier, D.P. Hesson, K.A. Jones, A.M. Costa, Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor, J. Med. Chem. 39 (1996) 343-346.
20. (e) J.T. Lazzaro, A.V. Paternain, J. Lerma, B.L. Chenard, F.E. Ewing, J. Huang, W.M. Welch, A.H. Ganong, F.S. Menniti, Functional characterization of CP-465,022, a Selective, noncompetitive AMPA receptor antagonist, Neuropharmacology 42 (2002) 143-153.
21. Zheng F., Erreger K., Low C.M., Banke T., Lee C.J., Conn P.J., Traynelis S.F. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat. Neurosci. 4:2001;894-901.